Potential of AI for the Treatment of Acute Respiratory Distress Syndrome (ARDS)

被引:1
|
作者
Bickenbach, Johannes [1 ,2 ]
机构
[1] Univ Klinikum RWTH Aachen, Klin Operat Intens Med & Intermediate Care, Aachen, Germany
[2] Uniklin RWTH Aachen, Klin Operat Intens Med & Intermediate Care, Pauwelsstr 30, D-52074 Aachen, Germany
关键词
ARDS; Outcome; acute respiratory distress syndrome; artificial intelligence; machine learning; clinical decision support; digital medicine; SCORE;
D O I
10.1055/a-2043-8644
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Acute respiratory distress syndrome (ARDS) is still associated with high mortality rates and poses a significant, vital threat to ICU patients because this syndrome is often detected too late (or not at all), and timely therapy and the fastest possible elimination of the underlying causes thus fail to materialize. Artificial Intelligence (AI) solutions can enable clinicians to make every minute in the ICU work for the patient by processing and analyzing all relevant data, thus supporting early diagnosis, adhering to clinical guidelines, and even providing a prognosis for the course of the ICU. This article shows what is already possible and where further challenges lie in this field of digital medicine.
引用
收藏
页码:34 / 44
页数:11
相关论文
共 50 条
  • [31] Aspirin as a potential treatment in sepsis or acute respiratory distress syndrome
    Toner, Philip
    McAuley, Danny Francis
    Shyamsundar, Murali
    CRITICAL CARE, 2015, 19
  • [32] Aspirin as a potential treatment in sepsis or acute respiratory distress syndrome
    Philip Toner
    Danny Francis McAuley
    Murali Shyamsundar
    Critical Care, 19
  • [33] The early inflammatory response in acute respiratory distress syndrome (ARDS)
    Hirani, N
    Donnelly, SC
    ACUTE RESPIRATORY DISTRESS SYNDROME: CELLULAR AND MOLECULAR MECHANISMS AND CLINICAL MANAGEMENT, 1998, 297 : 153 - 158
  • [34] Incidence of acute respiratory distress syndrome (ARDS) in Olmsted county
    Preventza, O
    Schroeder, DR
    Decker, PA
    Wilson, GA
    Teska, BJ
    Zietlow, SP
    Harrison, BA
    Murray, M
    CRITICAL CARE MEDICINE, 1999, 27 (12) : A126 - A126
  • [35] Acute respiratory distress syndrome (ARDS) secondary to talc pleurodesis
    Kelly, Martin G.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2007, 18 (08) : 611 - 611
  • [36] Aerosolized prostacyclins for acute respiratory distress syndrome (ARDS) (Review)
    Afshari, Arash
    Bille, Anders Bastholm
    Allingstrup, Mikkel
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (07):
  • [37] Mechanisms of Pulmonary Hypertension in Acute Respiratory Distress Syndrome (ARDS)
    Revercomb, Lucy
    Hanmandlu, Ankit
    Wareing, Nancy
    Akkanti, Bindu
    Karmouty-Quintana, Harry
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 7
  • [38] Complexity of inflammatory mediators in acute respiratory distress syndrome (ARDS)
    Schears, GJ
    Costarino, AT
    JOURNAL OF PEDIATRICS, 1999, 135 (02): : 144 - 146
  • [39] A SYSTEMATIC REVIEW OF PHARMACOTHERAPIES FOR ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)
    Duggal, A.
    Ganapathy, A.
    Ratnapalan, M.
    Tsang, J.
    Sinuff, T.
    Burns, K. E.
    Meade, M. O.
    Adhikari, N.
    INTENSIVE CARE MEDICINE, 2012, 38 : S165 - S165
  • [40] Chronic Inflammatory Diseases and the Acute Respiratory Distress Syndrome ( ARDS)
    Fernandez-Bustamante, Ana
    Repine, John E.
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (09) : 1400 - 1408